Voss Capital LP raised its stake in shares of Rentokil Initial plc (NYSE:RTO - Free Report) by 21.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,090,287 shares of the company's stock after acquiring an additional 540,287 shares during the period. Rentokil Initial makes up 5.8% of Voss Capital LP's holdings, making the stock its 6th biggest holding. Voss Capital LP owned approximately 0.61% of Rentokil Initial worth $78,246,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also made changes to their positions in RTO. Virtu Financial LLC purchased a new stake in Rentokil Initial during the 3rd quarter worth approximately $295,000. Synovus Financial Corp grew its stake in shares of Rentokil Initial by 88.9% in the third quarter. Synovus Financial Corp now owns 190,025 shares of the company's stock worth $4,737,000 after acquiring an additional 89,452 shares in the last quarter. Peapack Gladstone Financial Corp increased its position in shares of Rentokil Initial by 5.1% during the third quarter. Peapack Gladstone Financial Corp now owns 302,919 shares of the company's stock worth $7,552,000 after acquiring an additional 14,745 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Rentokil Initial by 160.4% in the third quarter. JPMorgan Chase & Co. now owns 6,803 shares of the company's stock valued at $170,000 after acquiring an additional 4,190 shares in the last quarter. Finally, Harbour Capital Advisors LLC purchased a new position in Rentokil Initial in the fourth quarter valued at $271,000. 9.91% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Rentokil Initial in a research report on Friday, March 7th. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy".
Check Out Our Latest Analysis on Rentokil Initial
Rentokil Initial Stock Up 1.2 %
NYSE:RTO traded up $0.27 during trading hours on Friday, hitting $23.03. The company's stock had a trading volume of 431,637 shares, compared to its average volume of 765,730. The stock has a market capitalization of $11.63 billion, a P/E ratio of 15.25, a price-to-earnings-growth ratio of 7.95 and a beta of 1.07. The company has a current ratio of 1.04, a quick ratio of 0.96 and a debt-to-equity ratio of 0.75. The stock has a fifty day moving average of $22.90 and a 200-day moving average of $24.41. Rentokil Initial plc has a 52-week low of $19.60 and a 52-week high of $34.07.
Rentokil Initial Dividend Announcement
The firm also recently announced a semi-annual dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 4th will be given a dividend of $0.3825 per share. This represents a dividend yield of 2.4%. The ex-dividend date of this dividend is Friday, April 4th. Rentokil Initial's dividend payout ratio (DPR) is presently 43.71%.
Rentokil Initial Profile
(
Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
See Also

Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.